10x Genomics to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
August 31, 2021 16:05 ET
|
10x Genomics, Inc.
PLEASANTON, Calif., Aug. 31, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the Morgan Stanley 19th Annual Global Healthcare...
10x Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit
August 06, 2021 08:00 ET
|
10x Genomics, Inc.
PLEASANTON, Calif., Aug. 06, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the upcoming UBS Genomics 2.0 and MedTech Innovations...
10x Genomics Reports Second Quarter 2021 Financial Results
August 04, 2021 16:05 ET
|
10x Genomics, Inc.
PLEASANTON, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the second quarter ended June 30, 2021. Recent Highlights Revenue was...
10x Genomics Signs Global Patent Cross License Agreement with Bio-Rad
July 27, 2021 06:30 ET
|
10x Genomics, Inc.
Agreement to Cross License Single Cell Technologies Ends all Ongoing Legal Disputes PLEASANTON, Calif., July 27, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today announced that it...
10x Genomics Introduces New Chromium X Series for Single Cell Analysis
July 14, 2021 08:00 ET
|
10x Genomics, Inc.
PLEASANTON, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Building on its industry leading position in single cell analysis, 10x Genomics (NASDAQ: TXG) today announced commercial availability of its new...
10x Genomics to Report Second Quarter Financial Results on August 4, 2021
July 07, 2021 16:03 ET
|
10x Genomics, Inc.
PLEASANTON, Calif., July 07, 2021 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the second quarter 2021 after market close on Wednesday, August...
10x Genomics Unlocks Whole Transcriptome Analysis in FFPE Tissues With New Visium Assay, Now Shipping
June 10, 2021 08:00 ET
|
10x Genomics, Inc.
PLEASANTON, Calif., June 10, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today announced it is shipping its new Visium Spatial Gene Expression for FFPE (formalin-fixed and...
10x Genomics to Participate in Upcoming June Investor Conferences
May 24, 2021 08:00 ET
|
10x Genomics, Inc.
PLEASANTON, Calif., May 24, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating virtually in the following investor conferences: William...
10x Genomics Reports First Quarter 2021 Financial Results
May 05, 2021 16:03 ET
|
10x Genomics, Inc.
PLEASANTON, Calif., May 05, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the first quarter ended March 31, 2021. Recent Highlights Revenue was...
10x Genomics to Present at the BofA Securities 2021 Virtual Healthcare Conference
April 29, 2021 16:05 ET
|
10x Genomics, Inc.
PLEASANTON, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the upcoming BofA Securities 2021 Virtual Healthcare...